BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 30888485)

  • 1. Lesion detection performance of an abbreviated gadoxetic acid-enhanced MRI protocol for colorectal liver metastasis surveillance.
    Canellas R; Patel MJ; Agarwal S; Sahani DV
    Eur Radiol; 2019 Nov; 29(11):5852-5860. PubMed ID: 30888485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma detection: diagnostic performance of a simulated abbreviated MRI protocol combining diffusion-weighted and T1-weighted imaging at the delayed phase post gadoxetic acid.
    Besa C; Lewis S; Pandharipande PV; Chhatwal J; Kamath A; Cooper N; Knight-Greenfield A; Babb JS; Boffetta P; Padron N; Sirlin CB; Taouli B
    Abdom Radiol (NY); 2017 Jan; 42(1):179-190. PubMed ID: 27448609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abbreviated MRI for Secondary Surveillance of Recurrent Hepatocellular Carcinoma After Presumed Curative Treatment.
    Jeon SK; Lee DH; Hur BY; Park SJ; Kim SW; Park J; Suh KS; Lee KW; Yi NJ; Han JK
    J Magn Reson Imaging; 2023 Nov; 58(5):1375-1383. PubMed ID: 36825827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance.
    Marks RM; Ryan A; Heba ER; Tang A; Wolfson TJ; Gamst AC; Sirlin CB; Bashir MR
    AJR Am J Roentgenol; 2015 Mar; 204(3):527-35. PubMed ID: 25714281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor.
    Hayoz R; Vietti-Violi N; Duran R; Knebel JF; Ledoux JB; Dromain C
    Eur Radiol; 2020 Dec; 30(12):6593-6602. PubMed ID: 32601948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of gadoxetic acid-enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection.
    Granata V; Fusco R; de Lutio di Castelguidone E; Avallone A; Palaia R; Delrio P; Tatangelo F; Botti G; Grassi R; Izzo F; Petrillo A
    BMC Gastroenterol; 2019 Jul; 19(1):129. PubMed ID: 31340755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases.
    Chung WS; Kim MJ; Chung YE; Kim YE; Park MS; Choi JY; Kim KW
    J Magn Reson Imaging; 2011 Aug; 34(2):345-53. PubMed ID: 21702068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Performance of Abbreviated Liver MRI for the Follow-Up of Patients With Colorectal Liver Metastases.
    Torkzad MR; Riddell AM; Chau I; Cunningham D; Koh DM
    AJR Am J Roentgenol; 2021 Mar; 216(3):669-676. PubMed ID: 33502225
    [No Abstract]   [Full Text] [Related]  

  • 9. Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.
    Vietti Violi N; Lewis S; Liao J; Hulkower M; Hernandez-Meza G; Smith K; Babb JS; Chin X; Song J; Said D; Kihira S; Sirlin CB; Reeder SB; Bashir MR; Fowler KJ; Ferket BS; Sigel K; Taouli B
    Eur Radiol; 2020 Nov; 30(11):6003-6013. PubMed ID: 32588209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic performance of a simulated "short" gadoxetic acid-enhanced MRI protocol is similar to that of a conventional protocol for the detection of colorectal liver metastases.
    Ghorra C; Pommier R; Piveteau A; Rubbia-Brandt L; Vilgrain V; Terraz S; Ronot M
    Eur Radiol; 2021 Apr; 31(4):2451-2460. PubMed ID: 33025173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined gadoxetic acid and gadofosveset enhanced liver MRI for detection and characterization of liver metastases.
    Bannas P; Bookwalter CA; Ziemlewicz T; Motosugi U; Munoz Del Rio A; Potretzke TA; Nagle SK; Reeder SB
    Eur Radiol; 2017 Jan; 27(1):32-40. PubMed ID: 27137648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of liver malignancy with gadoxetic acid-enhanced MRI: is addition of diffusion-weighted MRI beneficial?
    Kim YK; Kim CS; Han YM; Lee YH
    Clin Radiol; 2011 Jun; 66(6):489-96. PubMed ID: 21367403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadoxetic acid-enhanced MRI and diffusion-weighted imaging for the detection of colorectal liver metastases after neoadjuvant chemotherapy.
    Yu MH; Lee JM; Hur BY; Kim TY; Jeong SY; Yi NJ; Suh KS; Han JK; Choi BI
    Eur Radiol; 2015 Aug; 25(8):2428-36. PubMed ID: 25899413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disappearing or residual tiny (≤5 mm) colorectal liver metastases after chemotherapy on gadoxetic acid-enhanced liver MRI and diffusion-weighted imaging: Is local treatment required?
    Kim SS; Song KD; Kim YK; Kim HC; Huh JW; Park YS; Park JO; Kim ST
    Eur Radiol; 2017 Jul; 27(7):3088-3096. PubMed ID: 27815722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of diffusion-weighted imaging in the detection of hepatic metastases from colorectal cancer: A comparison with unenhanced and Gd-EOB-DTPA enhanced MRI.
    Colagrande S; Castellani A; Nardi C; Lorini C; Calistri L; Filippone A
    Eur J Radiol; 2016 May; 85(5):1027-34. PubMed ID: 27130067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent gadoxetic acid.
    Lee KH; Lee JM; Park JH; Kim JH; Park HS; Yu MH; Yoon JH; Han JK; Choi BI
    Korean J Radiol; 2013; 14(6):894-904. PubMed ID: 24265564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of non-contrast abbreviated MRI and alpha foetoprotein has high performance for hepatocellular carcinoma screening.
    Girardet R; Dubois M; Manasseh G; Jreige M; Du Pasquier C; Canniff E; Gulizia M; Bonvin M; Aleman Y; Taouli B; Fraga M; Dromain C; Vietti Violi N
    Eur Radiol; 2023 Oct; 33(10):6929-6938. PubMed ID: 37464111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of focal liver lesions with gadoxetic acid-enhanced MRI: is a shortened delay time possible by adding diffusion-weighted imaging?
    Kim MY; Kim YK; Park HJ; Park MJ; Lee WJ; Choi D
    J Magn Reson Imaging; 2014 Jan; 39(1):31-41. PubMed ID: 24115329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases.
    Koh DM; Collins DJ; Wallace T; Chau I; Riddell AM
    Br J Radiol; 2012 Jul; 85(1015):980-9. PubMed ID: 22167501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abbreviated Gadoxetic Acid-Enhanced MRI for the Detection of Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Adenocarcinoma.
    Yamaguchi T; Sofue K; Ueshima E; Ueno Y; Tsujita Y; Yabe S; Shirakawa S; Toyama H; Hori M; Fukumoto T; Murakami T
    J Magn Reson Imaging; 2022 Sep; 56(3):725-736. PubMed ID: 35005813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.